Cargando…
Serum Anti-Fumarate Hydratase Autoantibody as a Biomarker for Predicting Prognosis of Acute-on-Chronic Liver Failure
BACKGROUND/AIMS: To investigate the autoantibody against fumarate hydratase (FH), which is a specific liver failure-associated antigen (LFAA) and determine whether it can be used as a biomarker to evaluate the prognosis of acute-on-chronic liver failure (ACLF). METHODS: An immunoproteomic approach w...
Autores principales: | Wei, Linlin, Wang, Ting, Chen, Sisi, Liu, Yeying, Huang, Xueying, Zheng, Sujun, Xu, Bin, Ren, Feng, Liu, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502492/ https://www.ncbi.nlm.nih.gov/pubmed/36317513 http://dx.doi.org/10.5009/gnl220022 |
Ejemplares similares
-
HIF and fumarate hydratase in renal cancer
por: Sudarshan, S, et al.
Publicado: (2007) -
Structural basis of fumarate hydratase deficiency
por: Picaud, Sarah, et al.
Publicado: (2011) -
Inhibition of Mitochondrial Aconitase by Succination in Fumarate Hydratase Deficiency
por: Ternette, Nicola, et al.
Publicado: (2013) -
Identification
of Fumarate Hydratase Inhibitors with
Nutrient-Dependent Cytotoxicity
por: Takeuchi, Toshifumi, et al.
Publicado: (2014) -
Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism
por: Valcarcel-Jimenez, Lorea, et al.
Publicado: (2023)